Summary
Global Markets Direct’s “Dainippon Sumitomo Pharma Co., Ltd. - Financial and Strategic Analysis Review†is an in-depth business, strategic and financial analysis of Dainippon Sumitomo Pharma Co., Ltd. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.
Dainippon Sumitomo Pharma Co., Ltd. (DSP) is a Japan-based pharmaceutical company engaged in manufacturing and selling pharmaceuticals, veterinary products, food additives, industrial chemicals, and other chemical products. The company conducts its sales and marketing operations through 22 branches and 55 sales offices through out Japan. The company carries out its operations through 11 subsidiaries and seven associated companies. It is headquartered in Osaka-shi, Osaka, Japan. In January 2009, the company’s Parkinson's disease drug TRERIEF received manufacturing and marketing approval. In March 2009, it launched PRONAMID ,a gastro-prokinetic agent for dogs.
Recent Developments
Sep 03, 2009: DSP To Acquire Sepracor For $2.6 Billion
Oct 14, 2009: Dainippon Sumitomo, Sepracor Completes Aptiom's Tender Offer
Oct 20, 2009: DSP Completes Acquisition Of Sepracor
Scope
- Provides key company information for business intelligence needs
- The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
- The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
- The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- A quick “one-stop-shop†to understand the company.
- Enhance business/sales activities by understanding customers’ businesses better.
- Get detailed information and financial & strategic analysis on companies operating in your industry.
- Identify prospective partners and suppliers - with key data on their businesses and locations.
- Capitalize on competitors’ weaknesses and target the market opportunities available to them.
- Compare your company’s financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.